QUOTE AND NEWS
Benzinga  Jun 22  Comment 
Shares of Tesla Motors Inc (NASDAQ: TSLA) lost almost 11 percent on Wednesday following the company’s bid to buy SolarCity Corp (NASDAQ: SCTY). Of course, this was all Tesla analysts could talk about on Wednesday. Among the numerous firms...
Benzinga  Jun 13  Comment 
Piper Jaffray's Brett Wong maintains Monsanto Company (NYSE: MON)'s Overweight rating, while increasing the price target from $95.00 to $127.00. The price objective increase came during ongoing talks with Bayer AG (ADR) (OTC: BAYRY) to acquire...
Benzinga  Jun 10  Comment 
Piper Jaffray’s Alexander E. Potter believes General Motors Company (NYSE: GM) shares are currently offer cheap valuation, stable outlook and attractive dividend yield of 5.1 percent. Potter initiated coverage of the company with an...
Benzinga  Jun 10  Comment 
Piper Jaffray's Alexander Potter initiated Autoliv Inc. (NYSE: ALV) at Neutral with a price target of $123.00. Autoliv "exhibits an above-average growth profile," said Potter. The analyst attributed the company's strength partly due to the trend...
Benzinga  Jun 10  Comment 
Piper Jaffray’s Alexander E. Potter believes that Mobileye NV (NYSE: MBLY) is a compelling stock for “investors seeking a defensible story with exposure to the fast-growing market for advanced car safety.” Potter initiated coverage of the...
Benzinga  Jun 8  Comment 
Piper Jaffray analysts Nicole Miller Regan and Joshua Long have reiterated their Overweight rating on Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY). They have increased their price target to $51.00 from $49.00 on the company's stock. The...
Benzinga  Jun 8  Comment 
Piper Jaffray's Peter Keith maintains Mattress Firm Holding Corp (NASDAQ: MFRM)'s Neutral rating with a $35.00 price target. The reiteration came a day before Mattress Firm was scheduled to report earnings. "While MFRM has done an excellent job...
Benzinga  Jun 7  Comment 
Ahead of Piper Jaffray’s 36th annual consumer conference, analysts Neely J.N. Tamminga and Kayla R. Wesser shared their “high-level insights into why mall-based retailing still matters.” Nine companies in the firm’s coverage universe...
Benzinga  Jun 7  Comment 
At the ASCO Conference on Monday, Vascular Biogenics Ltd (NASDAQ: VBLT) reported the updated response rate and mOS results for the ongoing Phase I/II trials of VB-111 in platinum-resistant ovarian cancer. Piper Jaffray’s Charles C. Duncan...





You may also be interested in articles related to Piper Jaffray Companies (PJC):
 




You have more usfuel info than the British had colonies pre-WWII.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki